Eli Lilly

An experimental weight-loss injection has helped people with obesity lose an average of up to 25 per cent…

A move by a multi-billion-dollar global pharmaceutical company to bypass bricks and mortar pharmacies and deliver its GLP-1…

Hundreds of Americans are suing GLP-1 drugmakers Novo Nordisk and Ely Lilly, saying they were not adequately warned…

The pharmaceutical market is currently defined by a race to replace aging blockbusters with next-generation therapies. Deciding whether…

For patients living with Type 2 diabetes in the United Kingdom, a more convenient treatment option may be…

On August 5, Eli Lilly (NYSE:LLY) told investors its second quarter delivered 48% revenue growth, and the days…

Eli Lilly pharmaceuticals CEO David Ricks says he still wants to reach an agreement with the Australian government…

New Delhi: After a brief slowdown, sales of generic versions of the weight-loss drug semaglutide recorded a strong…

Eli Lilly and Company LLY will report its second-quarter 2026 earnings on Aug. 5, before market open. The Zacks…

KENT COUNTY, Mich — A new weight loss drug could soon be joining the growing list of medications…

Find winning stocks in any market cycle. Join 7 million investors using Simply Wall St’s investing ideas for…

Investing.com — Eli Lilly announced Thursday it will file for approval of its next-generation obesity drug retatrutide in…

Ozempic Rival Retatrutide Delivers 25% Weight Loss In Phase 3 Trial